企業プロフィール
Oncolytics Biotech Inc. 株価・ニュース・カタリスト
- ティッカー:
- ONCY
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Canada and listed in the U
株価パフォーマンス
0.82 USD (-1.35%)
終値
最終更新: 2026年8月17日
111M USD
時価総額
株価変動の要因
The latest monitored company update is “Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer.” The corresponding closing-price reaction is not yet available.
企業概要
事業概要
Oncolytics Biotech is an oncology company focused on oncolytic virus therapy and immune activation in cancer. Its story is built around using a viral platform to trigger stronger anti-tumor responses in difficult solid tumors.
所在地とセクター分類
Oncolytics is headquartered in Canada and listed in the U.S. market. It sits in small-cap oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical validation, translational confidence, and capital support while it develops a narrow cancer platform. Investors usually watch efficacy, safety, and partnership interest.
バイオ業界での位置付け
Oncolytics occupies a specialized oncolytic-virus niche within biotech. The stock is catalyst-sensitive because the market still needs proof that the platform can create durable clinical value.
今後のカタリスト
- Oncolytics’ catalysts are pelareorep and the oncology-combination program, where the next clinical update can materially move the stock. The company remains highly dependent on human data.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。